Drug · DIN 02498464
CLINIMIX
8% AMINO ACIDS (BLEND D) WITHOUT ELECTROLYTES IN 14% DEXTROSE INJECTION
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 19, 2020; first marketed November 19, 2020.
- Drug Identification Number (DIN)
- 02498464
- Company (DIN owner)
- Baxter CorporationMississauga, Ontario, Canada
- Schedule
- Ethical
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Combinations B05BA10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ALANINE | 1656 MG | 100 ML |
| L-ARGININE | 920 MG | 100 ML |
| GLYCINE | 824 MG | 100 ML |
| HISTIDINE | 384 MG | 100 ML |
| L-ISOLEUCINE | 480 MG | 100 ML |
| L-LEUCINE | 584 MG | 100 ML |
| L-LYSINE HYDROCHLORIDE | 464 MG | 100 ML |
| METHIONINE | 320 MG | 100 ML |
| L-PHENYLALANINE | 448 MG | 100 ML |
| L-PROLINE | 544 MG | 100 ML |
| SERINE | 400 MG | 100 ML |
| L-THREONINE | 336 MG | 100 ML |
| TRYPTOPHAN | 144 MG | 100 ML |
| L-TYROSINE | 32 MG | 100 ML |
| L-VALINE | 464 MG | 100 ML |
| DEXTROSE | 14 G | 100 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 29, 2020: NOC 23678Supplement to a New Drug Submission (SNDS) · Additional strengths
Other DINs named CLINIMIX
- DIN 02013886 · Marketed
- DIN 02013932 · Marketed
- DIN 02013940 · Marketed
- DIN 02046709 · Marketed
- DIN 02498448 · Marketed
- DIN 02498456 · Marketed
- DIN 02013916 · Cancelled Post Market
- DIN 02013924 · Cancelled Post Market
- DIN 02013959 · Cancelled Post Market
- DIN 02142260 · Cancelled Post Market
- DIN 02142279 · Cancelled Post Market